News Category
Viromed Medical AG signs distribution agreements for ViroCAP® in Spain, Portugal, Greece, the Balkans, Romania, and Saudi Arabia, expecting at least 3...
Quantum BioPharma's FDA clearance to advance Lucid-MS into Phase 2 trials marks a pivotal step toward a potential neuroprotective therapy for multiple...
PX1 Research introduces a line of US-manufactured sublingual peptide strips, including Retatrutide, Tirzepatide, and BPC-157, offering a needle-free d...
PX1 Research's adoption of seven-stage HPLC purity testing and cGMP compliance for all US-made research peptides enhances supply chain transparency fo...
NanoViricides has received approval to begin a Phase II trial of its oral NV-387 gummies for Ebola in the DRC, potentially offering a more practical t...
University of Virginia researchers find focused ultrasound may enhance drug delivery to gliomas, offering a less harmful targeted treatment option for...
Telomir Pharmaceuticals announced peer-reviewed preclinical data showing Telomir-Zn suppresses tumor growth in prostate and triple-negative breast can...
Park-Ohio's second quarter results indicate a portfolio inflection with record gross margins and improved Engineered Products performance, leading to ...
ICON Smile Studios opens two flagship multidisciplinary campuses in Virginia Beach and Norfolk, marking a major expansion that integrates orthodontics...
Scinai Immunotherapeutics strengthens its CDMO platform with the appointment of Eran Kuratz, a seasoned executive, to oversee supply chain and busines...
Quantum BioPharma's FDA clearance to advance Lucid-MS into Phase 2 trials marks a pivotal step toward a novel neuroprotective treatment for multiple s...
Tonix Pharmaceuticals' Q2 2026 revenue jumped to $13.5 million driven by TONMYA sales, marking a significant commercial milestone and supporting its p...
Tonix Pharmaceuticals' second-quarter revenue surged to $13.5 million, driven by TONMYA sales, signaling commercial traction and financial stability.
Tonix Pharmaceuticals' Q2 2026 revenue jumped to $13.5 million, driven by strong TONMYA sales, signaling commercial success and pipeline progress.
Voyageur Pharmaceuticals advances its Mueller iodine extraction process with 99.8% purity and >90% recovery, moving to field pilot testing to establis...
OffScript introduces sublingual nootropic mints with fully disclosed ingredients and third-party testing, targeting the clean-label supplement market.
A new narrative review provides a comprehensive framework for risk-adapted diagnosis and treatment of neuroblastoma, emphasizing molecular markers and...
Regentis Biomaterials is progressing its GelrinC cartilage regeneration technology through clinical trials, FDA submission preparation, European comme...
Quantum BioPharma is progressing its pipeline with Lucid-MS for multiple sclerosis and unbuzzd for alcohol misuse, highlighting a two-pronged approach...
Quantum BioPharma is advancing a two-pronged approach to neurological health, with its MS drug candidate Lucid-MS and its supplement unbuzzd, highligh...
VERAXA Biotech's proprietary BiTAC platform positions it to capitalize on the growing antibody therapeutics market, attracting potential partnerships ...
A case in Spain where a patient's pork tapeworm infection mimicked brain cancer underscores the importance of proper food preparation and the need for...
Veetee USA appoints Kevin Stitt to spearhead retail expansion at Walmart and Publix, leveraging a differentiated cooking process and a new domestic ma...
Lantern Pharma's upcoming webcast will detail its Q2 2026 financial results and AI platform developments, underscoring its strategic pivot toward comm...
Earth Science Tech's fiscal first-quarter results show a 57% net income increase, highlighting its profitable growth and strategic expansion, which is...
Thorium Atomics has initiated pre-application regulatory engagement with the U.S. Nuclear Regulatory Commission for its Tesseract TGR advanced reactor...
VERAXA Biotech's VXA-222 bispecific ADC program moves to next development stage, backed by expanded intellectual property, highlighting progress in it...
American Fusion Inc. files six new patent applications and prepares for next-phase testing, signaling progress toward commercialization of its fusion ...
Nano-X Imaging announced an $8 million registered direct offering with a long-term institutional investor to strengthen its balance sheet and support ...
A novel liquid biopsy offers a simpler way to predict which advanced lung cancer patients will respond to immunotherapy, potentially improving treatme...
GeoVax announces completion of manufacturing, regulatory, clinical, and preclinical milestones for its GEO-MVA vaccine, positioning it for a pivotal P...
Innovative Designs, Inc. announces its fiscal Q3 2026 as the highest revenue quarter in company history, with nearly 40% sales growth year-over-year a...
The July Wellness Index Report reveals a growing trend in longevity medicine that emphasizes supporting the body's natural processes over overriding t...
The July Wellness Index Report reveals a shift in longevity from adding external interventions to leveraging the body's own hormones, cells, and micro...
Regentis Biomaterials' next-generation manufacturing for GelrinC, which boosts yield by 400%, positions the therapy as a cost-effective standard of ca...
Purple Exhibits announces Joey Bartman will provide expert oversight for all KBIS 2027 projects, emphasizing strategic guidance and quality control to...
Onco-Innovations is combining PNKP-targeted DDR inhibition, nanoparticle delivery, and AI to develop ONC010, potentially improving cancer treatment ef...
Earth Science Tech's strategic focus on proprietary technology and vertical integration positions it to capitalize on the growing telehealth and pepti...
Episode 812 of DH Unplugged dissects the market chaos from Big Tech earnings, the KOSPI crash, and SpaceX's post-IPO slide, highlighting the implicati...
Researchers at Nagoya University discovered that the ancient protein C3, when produced within tumors, can boost the effectiveness of immunotherapy by ...
American Fusion presented its Texatron Fusion Engine development and related GEM theory at the APS DPF 2026 Meeting, advancing its fusion energy resea...
VolitionRx's proprietary Capture-Seq technology, which isolates over 99% pure circulating tumor DNA, addresses a critical challenge in liquid biopsy a...
Tonix Pharmaceuticals' participation in key investor conferences underscores its strategic focus on advancing its CNS and immunology pipeline, includi...
VERAXA Biotech's VXA-222 bispecific ADC program moves past discovery, and the company expands its IP estate with new patent filings, strengthening its...
LataMed AI's participation in an educational conference at Universidad Santa Maria highlights the growing importance of artificial intelligence in hea...
NeuroThera Labs has initiated a Phase IIb clinical trial at Yale Child Study Center for SCI-110, a novel cannabinoid-based treatment for Tourette Synd...
Medios AG strengthens its capital markets expertise with the appointment of Katrin Neuffer, signaling a strategic push to enhance investor dialogue an...
SRX Global's investment in Vistagen underscores its strategy to unlock value in undervalued biopharmaceutical companies, potentially reshaping the neu...
